The ACTINO Skin test (U.S Patent Pending 18/607.817) is specifically designed for human health assessment, testing for 5 toxic actinomycetes species that colonize human skin: Corynebacterium amycolatum, C. simulans, C. tuberculostearicum, C. xerosis, and Propionibacterium acnes. These bacteria produce biotoxins that can trigger CIRS and contribute to molecular hypometabolism. The test offers two options: basic ACTINO Skin (5 species) or upgraded ACTINO Skin Index with 33 Human Habitat species and 10 Soil Habitat species. Sample collection involves skin swabs taken from behind the ears, with a 5-day turnaround time.
Stay in the loop with our monthly newsletter and be the first to know about new self-hosted software. We promise, no spam, just valuable updates.
The form has been successfully submitted.